Skip to main content

MARSHALL WACE, LLP

Position in SRPT — Sarepta Therapeutics, Inc.

CIK 1318757 LONDON, X0

Position in SRPT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$15,777,478
+$12,689,510 QoQ
Shares Held
725,068
+405.3% QoQ
Ownership
0.687%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2021
14 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in SRPT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

MARSHALL WACE, LLP holds $2,766,756,129 across 280 Biotechnology names. SRPT ranks #40 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SRPT

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $15,777,478 725,068
2025-12-31 $3,087,968 143,493
2025-09-30 $2,025,526 105,113
2025-03-31 $1,735,711 27,197
2024-09-30 $5,362,526 42,938
2024-06-30 $6,846,930 43,335
2024-03-31 $432,784 3,343
2023-09-30 $29,811,392 245,928
2023-06-30 $6,761,489 59,042
2023-03-31 $24,707,267 179,259
2022-12-31 $24,102,527 186,005
2021-12-31 $45,352,601 503,638
2021-09-30 $309,715 3,349
2021-03-31 $1,724,326 23,136